0001437749-16-034614.txt : 20160629
0001437749-16-034614.hdr.sgml : 20160629
20160629160125
ACCESSION NUMBER: 0001437749-16-034614
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20160628
FILED AS OF DATE: 20160629
DATE AS OF CHANGE: 20160629
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oxford Immunotec Global PLC
CENTRAL INDEX KEY: 0001586049
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
STATE OF INCORPORATION: X0
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
BUSINESS PHONE: 44 01235 442780
MAIL ADDRESS:
STREET 1: 94C INNOVATION DRIVE
STREET 2: MILTON PARK
CITY: ABINGDON
STATE: X0
ZIP: OX14 4RZ
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SANDBERG RICHARD A
CENTRAL INDEX KEY: 0001245055
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36200
FILM NUMBER: 161738838
MAIL ADDRESS:
STREET 1: 330 NEVEDA STREET
CITY: NEWTON
STATE: MA
ZIP: 02460-1458
4
1
rdgdoc.xml
FORM 4
X0306
4
2016-06-28
0001586049
Oxford Immunotec Global PLC
OXFD
0001245055
SANDBERG RICHARD A
C/O OXFORD IMMUNOTEC GLOBAL PLC
94C INNOVATION DRIVE
ABINGDON, OXFORDSHIRE
X0
OX14 4RZ
UNITED KINGDOM
1
SHARE OPTION (RIGHT TO BUY)
8.65
2016-06-28
4
A
0
7457
0
A
2026-06-28
ORDINARY SHARES
7457
7457
D
The option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant.
/s/ Anthony P. Ferman, as Attorney-in-Fact for Richard A. Sandberg
2016-06-29